808
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxic and potential anticancer constituents from the stems of Schisandra pubescens

, , , &
Pages 1204-1207 | Received 19 Nov 2012, Accepted 18 Jun 2013, Published online: 25 Jul 2013

References

  • Bao TT, Xu GF, Liu GT, et al. (1979). A comparison of the pharmacological actions of seven constituents isolated from fructus schizandrae. Yao Xue Xue Bao 14:1–7
  • Canel C, Moraes RM, Dayan FE, Ferreira D. (2000). Podophyllotoxin. Phytochemistry 54:115–20
  • Chen DF, Zhang SX, Xie L, et al. (1997). Anti-AIDS agents. 26. Structure--activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues. Bioorg Med Chem 5:1715–23
  • He F, Pu JX, Huang SX. (2010). Schinalactone A, a new cytotoxic triterpenoid from Schisandra sphenanthera. Org Lett 12:1208–11
  • Huang SX, Yang J, Xiao WL, et al. (2006). Three novel terpenoids from Schisandra pubescens var. pubinervis. Helv Chim Acta 89:1169–75
  • Huang ZH, Lu Y, Liu Y, et al. (2011). Kadsufolins A--D and related cytotoxic lignans from Kadsura oblongifolia. Helv Chim Acta 94:519–27
  • Ikeya Y, Taguchi H, Yosioka I. (1982). The constituents of Schisandra chinensis Baill. X. The structures of γ-schizanrin and four new lignans, (−)-gomisins L1 and L2, (±)-gomisin M1 and (+)-gomisin M2. Chem Pharm Bull 30:132–9
  • Ikeya Y, Taguchi H, Yosioka I, Kobayashi H. (1980). The constituents of Schisandra chinensis Baill. VIII. The structures of two new lignans, tigloylgomisin P and angeloylgomisin P. Chem Pharm Bull 28:3357–61
  • Kuo YH, Lin ST, Wu RE. (1989). Three new lignans from the nutmeg of Myristica cagayanesis. Chem Pharm Bull 37:2310–12
  • Li LN, Xue H. (1986). Triterpenoids from roots and stems of Kadsura coccinea. Planta Med 52:492–3
  • Li RT, Han QB, Zhao AH, Sun HD. (2003). Micranoic acids A and B: Two new octanortriterpenoids from Schisandra micrantha. Chem Pharm Bull 51:1174–6
  • Liu JS, Huang MF, Ayer WA, Bigam G. (1983). Schisanlactone B, a new triterpenoid from a Schisandra sp. Tetrahedron Lett 24:2355–8
  • Liu JS, Huang MF, Tao Y. (1988a). Anwuweizonic acid and manwuweizic acid, the putative anticancer principle of Schisandra propinqua. Can J Chem 66:414–15
  • Liu JS, Tao Y, Huang MF. (1988b). Studies on the constituents of Schisandra henryi. 5. The structures of wulignan A1, A2, epiwulignan A1 and epischisandrone. Acta Chim Sin 46:483–8
  • Ma WH, Lu Y, Huang H, et al. (2009). Schisanwilsonins A--G and related anti-HBV lignans from the fruits of Schisandra wilsoniana. Bioorg Med Chem 19:4958–62
  • Peng LH, Chen DF, Lan HX, et al. (1996). Anti-lipid peroxidation of gomisin J on liver mitochondria and cultured myocardial cells. Acta Pharmacol Sin 17:538–41
  • Skehan P, Storeng R, Scudiero D, et al. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107–12
  • Smejkal K, Slapetova T, Krmencik P, et al. (2010). Evaluation of cytotoxic activity of Schisandra chinensis lignans. Planta Med 76:1672–7
  • Sun HD, Qiu SX, Lin LZ. (1996). Nigranoic acid, a triterpenoid from Schisandra sphaerandra that inhibits HIV-1 reverse transcriptase. J Nat Prod 59:525–7
  • Sun YJ, Li ZL, Chen H, et al. (2011). Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi. Bioorg Med Chem Lett 21:3794–7
  • Wang W, Liu JZ, Han J, et al. (2006). New triterpenoids from Kadsura heteroclita and their cytotoxic activity. Planta Med 72:450–7
  • Xiao WL, Tian RR, Pu JX, et al. (2006). Triterpenoids from Schisandra lancifolia with anti-HIV-1 activity. J Nat Prod 69:277–9
  • Xu XM, Li L, Chen M. (2009). Chemical constituents of Schisandra pubescens. Zhongyaocai 32:1399–401

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.